A multi-center, randomized, double-blinded, parallel, placebo-controlled study to assess the efficacy and safety of shenqisuxin granule in complex coronary artery disease after pci: study protocol

HIGHLIGHTS

• who: Peili Wang and Keji Chen from the Capital Medical University, China have published the Article: A multi-center, randomized, double-blinded, parallel, placebo-controlled study to assess the efficacy and safety of Shenqisuxin granule in complex coronary artery disease after PCI: Study protocol, in the Journal: (JOURNAL) of June/14,/2022
• what: The trial is being conducted in four centers in China, including Xiyuan Hospital of CACMS, Dongzhimen Hospital of Beijing University of Chinese Medicine, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, and the Affiliated Hospital of Shanxi University of Chinese . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.